Genetic variations in the HGPRT, ITPA, IMPDH1, IMPDH2, and GMPS genes in Japanese individuals

Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 6, 2009, Pages 557-564

  Kudo, Mutsumi ^a   Saito, Yuka ^a   Sasaki, Takamitsu ^a   Akasaki, Hitomi ^a   Yamaguchi, Yuri ^a   Uehara, Moe ^a   Fujikawa, Kiyomi ^a   Ishikawa, Masaaki ^a   Hirasawa, Noriyasu ^b   Hiratsuka, Masahiro ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

GMPS; HGPRT; IMPDH1; IMPDH2; ITPA; Single nucleotide polymorphism

Indexed keywords

AZATHIOPRINE; GUANOSINE MONOPHOSPHATE SYNTHASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INORGANIC PYROPHOSPHATASE; INOSINATE DEHYDROGENASE; INOSINATE DEHYDROGENASE 1; INOSINATE DEHYDROGENASE 2; INOSINE TRIPHOSPHATE PYROPHOSPHATASE; MERCAPTOPURINE; SYNTHETASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ENZYME ACTIVITY; EXON; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; JAPANESE; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 73349087861     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.24.557     Document Type: Article

References (23)

1. Lennard, L., Welch, J. C. and Lilleyman, J. S.: Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity. Br. J. Clin. Pharmacol., 44: 455-461 (1997).
2. Sahasranaman, S., Howard, D. and Roy, S.: Clinical pharmacology and pharmacogenetics of thiopurines. Eur. J. Clin. Pharmacol., 64: 753-767 (2008).
3. Schwab, M., Schaffeler, E., Marx, C., Fischer, C., Lang, T., Behrens, C., Gregor, M., Eichelbaum, M., Zanger, U. M. and Kaskas, B. A.: Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics, 12: 429-436 (2002).
4. Ansari, A., Hassan, C., Duley, J., Marinaki, A., Shobowale-Bakre, E. M., Seed, P., Meenan, J., Yim, A. and Sanderson, J.: Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment. Pharmacol. Ther., 16: 1743-1750 (2002).
5. Lennard, L.: TPMT in the treatment of Crohn's disease with azathioprine. Gut., 51: 143-146 (2002).
6. Lennard, L.: The clinical pharmacology of 6-mercaptopurine. Eur. J. Clin. Pharmacol., 43: 329-339 (1992).
7. Tidd, D. M. and Paterson, A. R.: A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res., 34: 738-746 (1974).
8. Derijks, L. J., Gilissen, L. P., Hooymans, P. M. and Hommes, D. W.: Review article: thiopurines in inflammatory bowel disease. Aliment. Pharmacol. Ther., 24: 715-729 (2006).
9. Ishioka, S., Hiyama, K., Sato, H., Yamanishi, Y., McLeod, H. L., Kumagai, K., Maeda, H. and Yamakido, M.: Thiopurine methyltransferase genotype and the toxicity of azathioprine in Japanese. Intern. Med., 38: 944-947 (1999).
10. Relling, M. V., Hancock, M. L., Rivera, G. K., Sandlund, J. T., Ribeiro, R. C., Krynetski, E. Y., Pui, C. H. and Evans, W. E.: Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J. Natl. Cancer Inst., 91: 2001-2008 (1999).
11. Sumi, S., Marinaki, A. M., Arenas, M., Fairbanks, L., Shobowale-Bakre, M., Rees, D. C., Thein, S. L., Ansari, A., Sanderson, J., De Abreu, R. A., Simmonds, H. A. and Duley, J. A.: Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum. Genet., 111: 36-367 (2002).
12. Marinaki, A. M., Ansari, A., Duley, J. A., Arenas, M., Sumi, S., Lewis, C. M., Shobowale-Bakreel, M., Escuredo, E., Fairbanks, L. D. and Sanderson, J. D.: Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics, 14: 181-187 (2004).
13. Sasaki, T., Goto, E., Konno, Y., Hiratsuka, M. and Mizugaki, M.: Three novel single nucleotide polymorphisms of the human thiopurine S-methyltransferase gene in Japanese individuals. Drug Metab. Pharmacokinet., 21: 332-336 (2006).
14. Kudo, M., Moteki, T., Sasaki, T., Konno, Y., Ujiie, S., Onose, A., Mizugaki, M., Ishikawa, M. and Hiratsuka, M.: Functional characterization of human xanthine oxidase allelic variants. Pharmacogenet. Genomics, 18: 243-251 (2008).
15. Haglund, S., Taipalensuu, J., Peterson, C. and Almer, S.: IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations. Br. J. Clin. Pharmacol., 65: 69-77 (2008).
16. Carr, S. F., Papp, E., Wu, J. C. and Natsumeda, Y.: Characterization of human type I and type II IMP dehydrogenases. J. Biol. Chem., 268: 27286-27290 (1993).
17. Konno, Y., Natsumeda, Y., Nagai, M., Yamaji, Y., Ohno, S., Suzuki, K. and Weber, G.: Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines. J. Biol. Chem., 266: 506-509 (1991).
18. Nagai, M., Natsumeda, Y., Konno, Y., Hoffman, R., Irino, S. and Weber, G.: Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res., 51: 3886-3890 (1991).
19. Nagai, M., Natsumeda, Y. and Weber, G.: Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells. Cancer Res., 52: 258-261 (1992).
20. Colby, T. D., Vanderveen, K., Strickler, M. D., Markham, G. D. and Goldstein, B. M.: Crystal structure of human type II inosine monophosphate dehydrogenase: implications for ligand binding and drug design. Proc. Natl. Acad. Sci. USA, 96: 3531-3536 (1999).
21. Nimmesgern, E., Black, J., Futer, O., Fulghum, J. R., Chambers, S. P., Brummel, C. L., Raybuck, S. A. and Sintchak, M. D.: Biochemical analysis of the modular enzyme inosine 5′- monophosphate dehydrogenase. Protein Expr. Purif., 17: 282-289 (1999).
22. Vanderheiden, B. S.: Inosine triphosphate in human erythrocytes: a genetic trait. In: Processings of the Tenth Congress of the International Society of Blood Transfusion, Stockholm, 1964, pp540-548.
23. Lin, S., McLennan, A. G., Ying, K., Wang, Z., Gu, S., Jin, H., Wu, C., Liu, W., Yuan, Y., Tang, R., Xie, Y. and Mao, Y.: Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the itpa gene. J. Biol. Chem., 276: 18695-18701 (2001).